[Complete response in a case of anastomotic recurrence of rectal cancer treated with S-1 monotherapy].
Gan To Kagaku Ryoho
; 41(12): 1716-8, 2014 Nov.
Article
em Ja
| MEDLINE
| ID: mdl-25731306
A 63-year-old woman underwent a low anterior resection for rectal cancer in 2002.A n anastomotic recurrence was diagnosed in July 2011.S he rejected the possibility of colostomy as radical surgery.Chemotherapy consisting of capecitabine+ oxaliplatin (XELOX) or folinic acid, fluorouracil, and oxaliplatin (FOLFOX6) + bevacizumab were not possible because of high costs. In view of the lower costs and the potential for ambulation, S-1 monotherapy was started. After 3 months, a reduction in the recurrent lesion was observed.After 19 months, the recurrent lesion revealed a scar, which was judged by biopsy to be Group 1.We had achieved a pathological complete response (CR).The standard treatment for recurrent colon cancer is surgical resection or multidrug chemotherapy. However, in view of a patient's quality of life (QOL), S-1 monotherapy may be considered as a potential therapy.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ácido Oxônico
/
Neoplasias Retais
/
Tegafur
/
Recidiva Local de Neoplasia
/
Antimetabólitos Antineoplásicos
Limite:
Female
/
Humans
/
Middle aged
Idioma:
Ja
Ano de publicação:
2014
Tipo de documento:
Article